Kendra Norman, MS
Kendra Norman completed her BS in Biology at Stony Brook University. While at Stony Brook, her research involved investigating the efficacy of modified NSAIDs in the treatment of prostate cancer. There, she was also interested in understanding the mechanisms underlying racial disparities in response to chemotherapy.
When her mother received a diagnosis of dementia and eventually early onset Alzheimer’s disease, she became increasingly interested in understanding the pathological mechanisms underlying neurodegeneration. After completing her undergraduate degree, she received a MS in Biology at New York University. Her thesis work in the lab of Dr. Thomas Wisniewski studied proteomic differences between rapidly progressive Alzheimer’s disease and sporadic Alzheimer’s disease. Their goal was to ascertain mechanisms that underlie differences in Alzheimer’s disease progression rates.
Her primary interest in the Gan Lab is examining tau acetylation, and how this post-translational modification promotes tau aggregation in Alzheimer’s disease. She looks forward to contributing to research efforts to identify new biomarkers and therapeutic targets. When Kendra is not in the lab, she enjoys listening to music, bowling, and going to museums and Broadway plays!
Research Interests: Understanding how various neuroinflammatory pathways correlate with tau and amyloid deposition, and how targeting such pathways mitigate or prevent neurodegeneration
Hobbies: Traveling, Broadway shows, music, museums
